Hypotensive therapy in stroke survivors

scientific article published on 01 March 1970

Hypotensive therapy in stroke survivors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(70)91577-1
P698PubMed publication ID4190177

P2093author name stringA B Carter
P2860cites workBethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient ComparisonQ24683012
Cerebral vascular accidents in patients over the age of 60. II. PrognosisQ34241339
OBSERVATIONS ON INTRACEREBRAL ANEURYSMSQ51284020
The natural history of cerebrovascular disease.Q51314701
Variation of blood-pressure in untreated hypertensive outpatients.Q54513923
Cerebrovascular disease: trial of long-term anticoagulant therapy.Q54940711
Results of Hypotensive Therapy in Arterial HypertensionQ55501899
Treatment of hypertension with methyldopaQ71166827
Prognosis among survivors of ischemic strokeQ72294387
The occurrence and significance of intracerebral micro-aneurysmsQ72297430
Clinical experience with bethanidine in treatment of hypertensionQ72329788
Hypertension and cerebral infarctionQ72753318
Comparison of mortality rates in elderly hypertensive and normotensive hemiplegic patientsQ72799316
The natural history of cerebral thrombosisQ74443407
THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSIONQ76644397
Course and prognosis in spontaneous occlusions of cerebral arteriesQ78411361
PROSPECTS FOR PATIENTS WITH STROKES, WITH SPECIAL REFERENCE TO THE HYPERTENSIVE HEMIPLEGICQ78425063
Survival after non-haemorrhagic cerebrovascular accidents. A prospective studyQ79068561
Factors influencing the prognosis of cerebral thrombosis and infarction due to atherosclerosisQ79206821
Merits of reducing high blood-pressureQ79440640
Treatment of severe hypertension with methyldopaQ79512594
P433issue7645
P407language of work or nameEnglishQ1860
P304page(s)485-489
P577publication date1970-03-01
P1433published inThe LancetQ939416
P1476titleHypotensive therapy in stroke survivors
P478volume1

Reverse relations

cites work (P2860)
Q28193940A benefit-risk assessment of agents used in the secondary prevention of stroke
Q36650848A practical approach to hypertension.
Q40475907Acute cerebral infarction. Optimal management in older patients.
Q33756538Acute controlled hypotension and EEG in patients with hypertension and cerebrovascular disease
Q54652448Antihypertensive drug therapy.
Q24186039Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
Q33910165Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus
Q33768748Antihypertensive therapy in the prevention of stroke: what, when and for whom?
Q39091115Atherosclerotic cerebral infarction pathophysiologic aspects
Q33783596Blood Pressure Management for Stroke Prevention and in Acute Stroke
Q44408584Blood Pressure–Lowering for Secondary Prevention of Stroke: ACE Inhibition Is Not the Key
Q36304782Blood pressure in the elderly
Q37607096Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature
Q57689006Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack
Q66705706Blood-pressure-lowering effect of acute myocardial infarction
Q66705704Cardiac pacemakers
Q43782892Cardiovascular protection and blood pressure reduction: a meta-analysis
Q72570518Clinical experiences in arterial hypertension in the elderly
Q28360739Contribution of inappropriate treatment for hypertension to pathogenesis of stroke in the elderly
Q69466862Course of blood pressure after cerebral infarction and transient ischemic attack
Q71223656Current status of risk factors for stroke
Q22306359Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke : Gathering the Evidence
Q34487030Effectiveness of treatment with antihypertensive drugs and trends in mortality from stroke in the community.
Q34523921Financial expenditures for the care of cerebrovascular disease patients in an urban setting
Q56336831First-line drugs for hypertension
Q24239935First-line drugs for hypertension
Q35823947General practitioners' management of hypertension in elderly patients
Q24794311Generalizability of guidelines and physicians' adherence. Case study on the Sixth Joint National Commitee's guidelines on hypertension
Q40145347Geriatric Hypertension
Q34299778Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.
Q40587863Guidelines for the treatment of hypertension: a critical review
Q40172929Health Maintenance of the Elderly
Q44696693Hypertension and Strokes
Q71667553Hypertension and stroke
Q83358999Hypertension in the elderly
Q87402097Hypertension: is the sham procedure 'toxic' for renal denervation?
Q40167377Influence of hypotensive drug treatment on morbidity and mortality in elderly hypertensives - review of the published trials
Q63977549Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association
Q44945982Letter: Membranous nephropathy and hepatitis-B antigen
Q70024880Letter: Non-treatment of hypertension
Q37616383Lifestyle factors in hypertension drug research: systematic analysis of articles in a leading cochrane report
Q34053343Lowering of blood pressure for recurrent stroke prevention
Q24541570MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party
Q41333277Management of hypertension in acute intracerebral hemorrhage
Q24537145Mechanisms and management of stroke in the elderly.
Q67588661Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party
Q44117708Morbidity and Mortality in Hypertension
Q72566059Oxprenolol in the treatment of hypertension in the elderly
Q40092109Pathophysiologic considerations in the treatment of the elderly hypertensive patient
Q38622305Pharmacotherapy for hypertension in adults aged 18 to 59 years.
Q24240189Pharmacotherapy for hypertension in the elderly
Q66880965Randomised controlled trial of treatment for mild hypertension: design and pilot trial. Report of Medical Research Council Working Party on Mild to Moderate Hypertension
Q52258240Rehabilitation of hemiplegia: indices of assessment and prognosis.
Q40977152Risk and management of hypertension-related left ventricular hypertrophy
Q36554968Secondary prevention of stroke by blood pressure-lowering treatment.
Q72390070Standards for the hospital management of stroke patients
Q43974955Strokes and hypertension
Q41526401The Secondary Prevention of Coronary Artery Disease
Q36716898The importance of good blood pressure control in the prevention of stroke recurrence in hypertensive patients
Q34047545The management of high blood pressure in general practice
Q34219779The marriage of primary care and epidemiology: the Milroy lecture, 1974.
Q40802367The prevention of cardiovascular disease. Emphasis on secondary prevention.
Q66909999The results of carotid angiography in cerebral infarction in normotensive and hypertensive subjects
Q57746413The role of impaired cardiac function in atherothrombotic brain infarction: the Framingham study
Q24650335The total care of the arteriosclerotic patient
Q34448957The veterans trial and sequelae
Q39915780Therapy of complicated arterial hypertension
Q37078895Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death
Q40493838Treatment of stroke in older patients. A state of the art review
Q43746447Trends in prescribing hypotensive drugs and in mortality from stroke in Australia
Q81657334[Blood pressure and the brain]

Search more.